![DISCONTINUATION OF ANTICOAGULANT THERAPY AFTER A FIRST EVENT: SP DISCONTINUATION OF ANTICOAGULANT THERAPY AFTER A FIRST EVENT: SP](https://eska-publishing.com/1703-home_default/discontinuation-of-anticoagulant-therapy-after-a-first-event-sp.jpg)
![DISCONTINUATION OF ANTICOAGULANT THERAPY AFTER A FIRST EVENT: SP DISCONTINUATION OF ANTICOAGULANT THERAPY AFTER A FIRST EVENT: SP](https://eska-publishing.com/1703-home_default/discontinuation-of-anticoagulant-therapy-after-a-first-event-sp.jpg)
This study the methodology "solid" makes a decision strategy based on elements simple clinical and biological safely stop a anticoagulant therapy in women who had a first spontaneous venous thrombotic episode and treated for 5 to 7 months.
This study the methodology "solid" makes a decision strategy based on elements simple clinical and biological safely stop a anticoagulant therapy in women who had a first spontaneous venous thrombotic episode and treated for 5 to 7 months.